首页> 外国专利> Cyclopropyl dicarboxamides and analogues that present anti-cancer and anti-proliferative activities

Cyclopropyl dicarboxamides and analogues that present anti-cancer and anti-proliferative activities

机译:具有抗癌和抗增殖活性的环丙基二甲酰胺及其类似物

摘要

A compound of Formula I, or a pharmaceutically acceptable salt, enantiomer, stereoisomer, or tautomer thereof, wherein X is halogen; Z1 and Z2 are CR2; Z3 is CH; each R1 is independently and individually halogen, H, C1-C6 alkyl, branched C3-C7 alkyl, C3-C7 cycloalkyl, or -CN; each R2 is individually and independently H, halogen, C1-C6 alkyl, or cyano; R3 is -C (O) R4, -C (O) -C6-C10-aryl, -C (O) -C4-C6 heterocyclyl, or -C (O) -C5-C6 heteroaryl, where aryl is phenyl, naphthyl, tetrahydronaphthyl, indenyl, or indanyl; and with the proviso that when R3 is -C (O) -C4-C6 heterocyclyl, the heterocyclyl does not have an N to -C (O) binding point; R4 is C3-C8 cycloalkyl, C1-C7 alkyl, - (CH2) p-CN, - (CH2) p-OR6, - (CH2) p-NR6 (R7), - (CH2) p-SO2-C1- alkyl C6, - (CH2) p-aryl C6-C10, - (CH2) p-heteroaryl C5-C6, or - (CH2) p-heterocyclyl C4-C6, in which each alkyl or alkylene is optionally substituted with one or two C1-C6 alkyl; and aryl is phenyl, naphthyl, tetrahydronaphthyl, indenyl, or indanyl; each R6 and R7 is individually and independently H, C1-C6 alkyl, or branched C3-C8 alkyl; each cycloalkyl, aryl, heteroaryl, and heterocyclyl is independently substituted with - - (R25) m; each R25 is individually and independently C1-C6 alkyl, branched C3-C8 alkyl, halogen, - (CH2) m-CN, - (CH2) m-OR6, - (CH2) m-NR6 (R7), - (CH2) m-SO2-C1-C6-alkyl, - (CH2) mC (O) NR6 (R7), - (CH2) mC (O-heterocyclyl C4-C6, or - (CH2) m-heterocyclyl C4-C6, where each alkyl or alkylene is optionally substituted with one or two C1-C6 alkyl; each m is individually and independently 0, 1, 2 or 3; and p is 1, 2 or 3.
机译:式I化合物或其药学上可接受的盐,对映异构体,立体异构体或互变异构体,其中X为卤素; Z1和Z2为CR2; Z3为CH;每个R 1独立且独立地为卤素,H,C 1 -C 6烷基,支链C 3 -C 7烷基,C 3 -C 7环烷基或-CN;每个R 2独立且独立地为H,卤素,C 1 -C 6烷基或氰基; R 3是-C(O)R 4,-C(O)-C 6 -C 10芳基,-C(O)-C 4 -C 6杂环基或-C(O)-C 5 -C 6杂芳基,其中芳基是苯基,萘基,四氢萘基,茚基或茚满基;并且前提是当R3是-C(O)-C4-C6杂环基时,所述杂环基不具有N至-C(O)的结合点; R4是C3-C8环烷基,C1-C7烷基,-(CH2)对-CN,-(CH2)对-OR6,-(CH2)对-NR6(R7),-(CH2)对-SO2-C1-烷基C 6,-(CH 2)对-芳基C 6 -C 10,-(CH 2)对-杂环芳基C 5 -C 6或-(CH 2)对-杂环基C 4 -C 6,其中每个烷基或亚烷基任选地被一个或两个C 1取代-C 6烷基;芳基为苯基,萘基,四氢萘基,茚基或茚满基; R6和R7各自独立地为H,C1-C6烷基或支链C3-C8烷基。每个环烷基,芳基,杂芳基和杂环基独立地被-(R25)m取代;每个R 25分别且独立地为C 1 -C 6烷基,支链C 3 -C 8烷基,卤素,-(CH 2)m-CN,-(CH 2)m-OR 6,-(CH 2)m-NR 6(R 7),-(CH 2) m-SO2-C1-C6-烷基,-(CH2)mC(O)NR6(R7),-(CH2)mC(O-杂环基C4-C6或-(CH2)m-杂环基C4-C6烷基或亚烷基任选地被一个或两个C1-C6烷基取代;每个m分别独立地为0、1、2或3; p为1、2或3。

著录项

  • 公开/公告号ES2475741T3

    专利类型

  • 公开/公告日2014-07-11

    原文格式PDF

  • 申请/专利权人 DECIPHERA PHARMACEUTICALS LLC;

    申请/专利号ES20110719421T

  • 发明设计人 FLYNN DANIEL L.;KAUFMAN MICHAEL D.;

    申请日2011-04-29

  • 分类号A61K31/44;A61K31/505;A61P35;C07D213/75;C07D239/47;

  • 国家 ES

  • 入库时间 2022-08-21 15:55:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号